US Stock MarketDetailed Quotes

CASI CASI Pharmaceuticals

Watchlist
  • 5.5800
  • +0.1500+2.76%
Close Oct 18 16:00 ET
  • 5.5800
  • 0.00000.00%
Post 17:03 ET
86.27MMarket Cap-2748P/E (TTM)

CASI Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CASI Pharmaceuticals Q3 2024 Estimates Date

Currency：USDNov 14, 2024

Estimate YoY
Revenue
4.56M
-48.40%
EPS
-0.62
-77.16%
Analyst Rating
No Data

CASI Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 7.394M--
Nov 14, 20242024/Q3-- / 4.560M--
Aug 20, 20242024/Q23.979M / 4.431M--
May 20, 20242024/Q13.409M / 12.000M--
Apr 1, 20242023/Q46.874M / 9.412M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 7.394M--
Nov 14, 20242024/Q3-- / 4.560M--
Aug 20, 20242024/Q23.979M / 4.431M--
May 20, 20242024/Q13.409M / 12.000M--
Apr 1, 20242023/Q46.874M / 9.412M--

Unlock Free Earnings Estimates

CASI Pharmaceuticals Earnings Reports

  • CASI Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 16 08:33 ET

  • CASI Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)

    May 15 06:55 ET

  • CASI Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)

    Mar 28 16:07 ET

  • CASI Pharmaceuticals | 20-F: FY2023 Annual Report

    Mar 28 11:09 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data